FR EN

Back


16/05/2019
Idinvest Partners' Healthcare portfolio company DNA Script closes funding round to accelerate commercial operations in the US
With their innovative enzymatic technology, DNA Script has overcome many of the inefficiencies of today's synthetic DNA production and allows researchers to accelerate their experiments. This funding round will be used to accelerate the development of the company's first products and expand its teams both in New York and in Paris.

Download the pdf file





X

X

X